Giá của Metagenomi, Inc. Common Stock là bao nhiêu (MGX)

Giá của Metagenomi, Inc. Common Stock (MGX) là $1.21

Mũ thị trường của Metagenomi, Inc. Common Stock là gì (MGX)

Giới hạn thị trường của Metagenomi, Inc. Common Stock (MGX) là $45.55M

Lịch sử giá Metagenomi, Inc. Common Stock (MGX)

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

Năm	Hiệu suất
2026 (TTM)	-2.20%
2025	-48.40%
2024	0.00%

Năm

Hiệu suất

2026 (TTM)

-2.20%

2025

-48.40%

2024

0.00%

Công ty	Giá cổ phiếu	Thay đổi 1năm%	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	$539.14	35.65%	US
Argenx SE ARGX.US	$1.04K	56.21%	NL
CSL Limited CSL.AX	$119.69	-17.56%	AU
Lonza Group AG LONN.SW	$761.87	8.65%	CH
Moderna, Inc. MRNA.US	$130.43	397.46%	US

Công ty

Giá cổ phiếu

Thay đổi 1năm%

Quốc gia